Skip to main content

Latest stock market podcasts

Part 2 Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 18 January

Paulina Peters
January 18, 2022

Morning Bell 17 January

Sophia Mavridis
January 17, 2022

Weekly Wrap 14 January

Sophia Mavridis
January 14, 2022

Morning Bell 13 January

Paulina Peters
January 13, 2022

Morning Bell 12 January

Sophia Mavridis
January 12, 2022

Morning Bell 11 January

Paulina Peters
January 11, 2022

Morning Bell 10 January

Sophia Mavridis
January 10, 2022

Morning Bell 17 December

Sophia Mavridis
December 17, 2021

Morning Bell 16 December

Paulina Peters
December 16, 2021

Morning Bell 15 December

Sophia Mavridis
December 15, 2021

Morning Bell 14 December

Paulina Peters
December 14, 2021

Morning Bell 13 December

Sophia Mavridis
December 13, 2021